Sponsored by
Latest
Topics
Topics
Accounting & Tax
Corporate Finance
Human Capital
Risk & Compliance
Strategy
Technology
Featured
Q&A
Restoring Integrity: MiMedx CFO Pete Carlson
CFO Carlson helps biologics company MiMedx recover from an episode of revenue recognition fraud.
By
Vincent Ryan
| June 30, 2022
Read More
Resources
CFO Live
Sign Up
Menu
Topics
Accounting & Tax
Corporate Finance
Human Capital
Risk & Compliance
Strategy
Technology
Explore
Search
Latest
Resources
CFO Live
Sign Up
Sponsored by
Botox
M&A
Botox Maker Allergan Sold to AbbVie for $63B
AbbVie faces pressure to diversify its portfolio as Humira, the world’s best-selling drug, faces increased competition from cheaper versions in Europe.
By
Lauren Muskett
| June 25, 2019
Read More
Strategy
Allergan Buys CoolSculpting Company for $2.4B
The acquisition of Zeltiq Aesthetics' system for using cooling to eliminate fat cells gives Allergan access to the growing body-contouring market.
By
Matthew Heller
| February 13, 2017
Read More